TELA Bio Inc.

NASDAQ: TELA · Real-Time Price · USD
1.58
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.58
-0.05%
After-hours: Aug 15, 2025, 04:04 PM EDT

TELA Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
69.3M 58.45M 41.42M 29.46M
Cost of Revenue
22.81M 18.34M 14.37M 10.65M
Gross Profit
46.49M 40.11M 27.04M 18.81M
Operating Income
-34.12M -44.08M -39.01M -29.45M
Interest Income
n/a n/a n/a n/a
Pretax Income
-37.98M -46.66M -44.3M -33.28M
Net Income
-37.84M -46.66M -44.34M -33.28M
Selling & General & Admin
79.37M 74.57M 57.11M 41.52M
Research & Development
8.81M 9.62M 8.94M 6.74M
Other Expenses
-7.58M n/a n/a n/a
Operating Expenses
80.6M 84.19M 66.05M 48.26M
Interest Expense
5.29M 5.22M 4.05M 3.6M
Selling & Marketing Expenses
64.65M 59.68M 43.25M 29.06M
Cost & Expenses
103.42M 102.53M 80.42M 58.91M
Income Tax Expense
-144K n/a 41K 2.83M
Shares Outstanding (Basic)
28.53M 22.87M 16.27M 14.47M
Shares Outstanding (Diluted)
28.53M 22.87M 16.27M 14.47M
EPS (Basic)
-1.33 -2.04 -2.73 -2.3
EPS (Diluted)
-1.33 -2.04 -2.73 -2.3
EBITDA
-31.68M -40.63M -39.06M -29.14M
EBIT
-32.7M -41.44M -40.24M -29.68M
Depreciation & Amortization
1.01M 808K 1.19M 535K